BRIEF published on 09/18/2025 at 17:55, 11 months 24 days ago Mauna Kea and Endotherapeutics Introduce Cellvizio to Australia Global Expansion Medical Technology Cellvizio Food Intolerances Australia Launch
BRIEF published on 09/18/2025 at 17:55, 11 months 24 days ago Mauna Kea et Endotherapeutics introduisent Cellvizio en Australie Expansion Mondiale Technologie Médicale Cellvizio Intolérances Alimentaires Lancement En Australie
PRESS RELEASE published on 09/18/2025 at 17:50, 11 months 24 days ago Inside Information / Other news releases Mauna Kea Technologies and Endotherapeutics secure first Australian orders for Cellvizio system, expanding commercial presence with CellTolerance indication, paving the way for global market growth Australia Mauna Kea Technologies CellTolerance Endotherapeutics Cellvizio System
PRESS RELEASE published on 09/18/2025 at 17:50, 11 months 24 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies et Endotherapeutics annoncent les premières commandes australiennes de Cellvizio® et accélèrent l'expansion commerciale de CellTolerance® Australie Mauna Kea Technologies Cellvizio CellTolerance Endotherapeutics
BRIEF published on 09/12/2025 at 08:20, 1 year ago Mauna Kea Technologies : un plan de sauvegarde ambitieux Augmentation De Capital Plan De Sauvegarde Croissance Commerciale Endomicroscopie Réduction D'endettement
BRIEF published on 09/12/2025 at 08:20, 1 year ago Mauna Kea Technologies: an ambitious safeguard plan Business Growth Capital Increase Debt Reduction Backup Plan Endomicroscopy
PRESS RELEASE published on 09/12/2025 at 08:15, 1 year ago Informations privilégiées / Autres communiqués Mauna Kea Technologies révèle son plan de sauvegarde visant à assainir sa structure financière et à accélérer son développement. Les actionnaires, titulaires de titres et créanciers appelés à voter le plan Restructuration Financière Plan De Sauvegarde Vote Actionnaires Mauna Kea Technologies Développement Entreprise
PRESS RELEASE published on 09/12/2025 at 08:15, 1 year ago Inside Information / Other news releases Mauna Kea Technologies unveils outlines of safeguard plan to strengthen financial structure and resources. Shareholders, creditors convene to vote on the plan Shareholders Financial Structure Creditors Safeguard Plan Mauna Kea Technologies
BRIEF published on 08/29/2025 at 17:50, 1 year ago Mauna Kea Technologies Shares and Voting Rights Update Euronext Growth Paris Share Capital Voting Rights Equity Financing Mauna Kea Technologies
BRIEF published on 08/29/2025 at 17:50, 1 year ago Informations sur les actions et les droits de vote de Mauna Kea Technologies Euronext Growth Paris Capital Social Droit De Vote Financement Par Actions Mauna Kea Technologies
Published on 09/12/2026 at 02:35, 1 day 12 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 15 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 17 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 21 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 20 hours 55 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 7 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 16 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 16 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 19 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 19 hours ago Availability of the 2026 Interim Financial Report
